JP2000504696A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000504696A5 JP2000504696A5 JP1997528821A JP52882197A JP2000504696A5 JP 2000504696 A5 JP2000504696 A5 JP 2000504696A5 JP 1997528821 A JP1997528821 A JP 1997528821A JP 52882197 A JP52882197 A JP 52882197A JP 2000504696 A5 JP2000504696 A5 JP 2000504696A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU8012 | 1996-02-12 | ||
| AUPN8012A AUPN801296A0 (en) | 1996-02-12 | 1996-02-12 | Stabilised growth hormone formulation and method of preparation thereof |
| PCT/AU1997/000075 WO1997029767A1 (en) | 1996-02-12 | 1997-02-12 | Stabilised growth hormone formulation and method of preparation thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000504696A JP2000504696A (ja) | 2000-04-18 |
| JP2000504696A5 true JP2000504696A5 (ja) | 2004-11-18 |
| JP4255515B2 JP4255515B2 (ja) | 2009-04-15 |
Family
ID=3792327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52882197A Expired - Lifetime JP4255515B2 (ja) | 1996-02-12 | 1997-02-12 | 安定化された成長ホルモン処方物およびその製造方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6593296B1 (ja) |
| EP (1) | EP0889733B1 (ja) |
| JP (1) | JP4255515B2 (ja) |
| CN (1) | CN1132626C (ja) |
| AT (1) | ATE340587T1 (ja) |
| AU (1) | AUPN801296A0 (ja) |
| CA (1) | CA2246501C (ja) |
| DE (1) | DE69736739T2 (ja) |
| DK (1) | DK0889733T3 (ja) |
| HK (1) | HK1017851A1 (ja) |
| RU (1) | RU2191029C2 (ja) |
| TR (1) | TR199801558T2 (ja) |
| WO (1) | WO1997029767A1 (ja) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277410B1 (en) * | 1992-10-08 | 2001-08-21 | Supratek Pharma Inc. | Copolymer compositions for oral delivery |
| DE60038118T2 (de) * | 1999-07-12 | 2009-03-05 | Sandoz Ag | Formulierungen von wachstumshormonen |
| AT408721B (de) * | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| AU2001238540A1 (en) | 2000-02-24 | 2001-09-03 | Monsanto Technology Llc | Non-aqueous injectable formulations for extended release of somatotropin |
| MXPA03000073A (es) | 2000-06-26 | 2003-09-25 | Monsanto Technology Llc | Formulaciones que contienen agente tensioactivo no acuoso para la liberacion prolongada de somatrotopina. |
| US6664234B1 (en) | 2000-06-30 | 2003-12-16 | Monsanto Technology Llc | Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin |
| GB2371227A (en) * | 2001-01-10 | 2002-07-24 | Grandis Biotech Gmbh | Crystallisation - resistant aqueous growth hormone formulations |
| JP4610154B2 (ja) * | 2002-05-30 | 2011-01-12 | 大塚製薬株式会社 | 注射用製剤 |
| CN1744914A (zh) * | 2002-12-31 | 2006-03-08 | 阿尔特斯制药公司 | 人生长激素晶体和制备它们的方法 |
| EP1603588A2 (en) * | 2003-03-18 | 2005-12-14 | Ares Trading S.A. | Stabilisation of growth hormones in solution |
| CA2540172A1 (en) * | 2003-09-25 | 2005-03-31 | Cangene Corporation | Liquid human growth hormone formulation containing polyethylene glycol |
| JP4845741B2 (ja) * | 2003-12-23 | 2011-12-28 | ファルマシア コーポレーション | 安定な成長ホルモン液体製剤 |
| DK1740213T3 (da) * | 2004-04-07 | 2012-04-10 | Ares Trading Sa | Væskeformulering til væksthormoner |
| EA011673B1 (ru) | 2004-11-09 | 2009-04-28 | Арес Трейдинг С.А. | Способ очистки fsh |
| WO2007022799A1 (en) | 2005-08-26 | 2007-03-01 | Ares Trading S.A. | Process for the preparation of glycosylated interferon beta |
| JP5199112B2 (ja) | 2005-12-09 | 2013-05-15 | アレス トレーディング ソシエテ アノニム | Ｆｓｈ又はｆｓｈ変異体を精製するための方法 |
| LT2049148T (lt) * | 2006-07-06 | 2016-11-25 | Daewoong Co., Ltd. | Žmogaus augimo hormono skysta stabili kompozicija |
| CN105412910A (zh) * | 2006-07-06 | 2016-03-23 | 株式会社大熊 | 稳定的人生长激素液体制剂 |
| AU2009240026B2 (en) * | 2008-04-21 | 2014-05-29 | Novo Nordisk Health Care Ag | Dry transglutaminase composition |
| WO2013014196A1 (en) | 2011-07-25 | 2013-01-31 | Sandoz Ag | Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein |
| US10064951B2 (en) * | 2012-03-30 | 2018-09-04 | Hanmi Science Co., Ltd. | Liquid formulation of highly concentrated long-acting human growth hormone conjugate |
| KR102276304B1 (ko) * | 2013-09-27 | 2021-07-14 | 한미약품 주식회사 | 지속형 인간 성장 호르몬 제제 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB131864A (ja) | ||||
| DE3325223A1 (de) * | 1983-07-13 | 1985-01-24 | Hoechst Ag, 6230 Frankfurt | Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung |
| PT83095B (en) | 1985-07-30 | 1987-12-23 | Int Minerals & Chem Corp | Method for the stabilization of growth promoting hormones using polyoxyethylene-polyoxypropylene copolymers |
| IT1222395B (it) | 1987-07-30 | 1990-09-05 | Pierrel Spa | Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare |
| ATE82506T1 (de) | 1987-08-21 | 1992-12-15 | Imcera Group Inc | Stabilisierung von wachstumshormonen. |
| US5096885A (en) * | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
| GB8822857D0 (en) | 1988-09-29 | 1988-11-02 | Patralan Ltd | Pharmaceutical formulations |
| EP0374120A3 (en) * | 1988-12-13 | 1991-07-31 | Monsanto Company | Comosition for controlled release of polypeptides |
| US5013714A (en) * | 1988-12-15 | 1991-05-07 | Lindstrom Richard L | Viscoelastic solution |
| US4994439A (en) * | 1989-01-19 | 1991-02-19 | California Biotechnology Inc. | Transmembrane formulations for drug administration |
| US5182258A (en) | 1989-03-20 | 1993-01-26 | Orbon Corporation | Systemic delivery of polypeptides through the eye |
| US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
| US5210017A (en) * | 1990-11-19 | 1993-05-11 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
| SE9201073D0 (sv) | 1992-04-03 | 1992-04-03 | Kabi Pharmacia Ab | Protein formulation |
| CA2337745C (en) * | 1992-07-31 | 2005-04-12 | Genentech, Inc. | Human growth hormone aqueous formulation |
| JP3905921B2 (ja) * | 1992-10-02 | 2007-04-18 | ジェネティクス インスチチュート リミテッド ライアビリティー カンパニー | 凝固第▲ｖｉｉｉ▼因子を含む組成物及びその製造方法並びに安定剤としての界面活性剤の使用方法 |
| AU685784B2 (en) * | 1993-02-23 | 1998-01-29 | Genentech Inc. | Excipient stabilization of polypeptides treated with organic solvents |
| ATE317397T1 (de) * | 1993-11-17 | 2006-02-15 | Athena Neurosciences Inc | Transparente flüssigkeit zur verabreichung von verkapselten medikamenten |
-
1996
- 1996-02-12 AU AUPN8012A patent/AUPN801296A0/en not_active Abandoned
-
1997
- 1997-02-12 CA CA2246501A patent/CA2246501C/en not_active Expired - Fee Related
- 1997-02-12 RU RU98117135/14A patent/RU2191029C2/ru active
- 1997-02-12 CN CN97193316A patent/CN1132626C/zh not_active Expired - Fee Related
- 1997-02-12 EP EP97902109A patent/EP0889733B1/en not_active Revoked
- 1997-02-12 DE DE69736739T patent/DE69736739T2/de not_active Expired - Lifetime
- 1997-02-12 DK DK97902109T patent/DK0889733T3/da active
- 1997-02-12 JP JP52882197A patent/JP4255515B2/ja not_active Expired - Lifetime
- 1997-02-12 TR TR1998/01558T patent/TR199801558T2/xx unknown
- 1997-02-12 WO PCT/AU1997/000075 patent/WO1997029767A1/en active IP Right Grant
- 1997-02-12 US US09/125,267 patent/US6593296B1/en not_active Expired - Fee Related
- 1997-02-12 AT AT97902109T patent/ATE340587T1/de active
-
1999
- 1999-07-09 HK HK99102933A patent/HK1017851A1/xx not_active IP Right Cessation